Evidence map›Paper›PMID 31993256›Full record

ReviewApplications in plant sciences2020

Considerations in adapting CRISPR/Cas9 in nongenetic model plant systems.

Shengchen Shan, Pamela S Soltis, Douglas E Soltis, Bing Yang

Abstract readReview
In one paragraph

Review in Applications in plant sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Genome Editing Approaches in Flax (International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. DNA-free CRISPR genome editing in raspberry (Frontiers in genome editing · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Function Analysis of theInternational journal of molecular sciences · 2022
    Article
  19. Review
  20. The biology ofeLife · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shengchen ShanPlant Molecular and Cellular Biology Program University of Florida Gainesville Florida 32611-0180 USA.ORCID https://orcid.org/0000-0002-9472-0986
Pamela S SoltisPlant Molecular and Cellular Biology Program University of Florida Gainesville Florida 32611-0180 USA.ORCID https://orcid.org/0000-0001-9310-8659
Douglas E SoltisPlant Molecular and Cellular Biology Program University of Florida Gainesville Florida 32611-0180 USA.ORCID https://orcid.org/0000-0001-8638-4137
Bing YangDivision of Plant Sciences University of Missouri Columbia Missouri 65211 USA.ORCID https://orcid.org/0000-0002-2293-3384

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The past six years have seen the rapid growth of studies of CRISPR/Cas9 in plant genome editing, a method that enormously facilitates both basic research and practical applications. Most studies have focused on genetic model species, but plant species that are not genetic models may also be economically important or biologically significant, or both. However, developing the CRISPR/Cas9 system in a nongenetic model is challenging. Here, we summarize CRISPR/Cas9 applications in 45 plant genera across 24 families and provide a reference for practical application of CRISPR in nongenetic model plant systems. Suggestions for selecting plant species and target genes are given for proof-of-principle CRISPR studies, and the processes of vector construction are reviewed. We recommend using transient assays to identify a desired CRISPR/Cas9 system in a nongenetic model. We then review methods of plant transformation and describe approaches, using regenerated transgenic plants, for evaluating CRISPR editing results. Lastly, potential future applications of CRISPR in nongenetic model plant species are discussed. This review provides a road map for developing CRISPR in nongenetic models, an application that holds enormous potential in plant biology.

Indexed as

CRISPR/Cas9genome editingnongenetic model

Identifiers

PMID31993256
PMCPMC6976890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.